This Week’s Life Science Headlines November 15, 2013 / Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Preemption Recalls Regulatory Settlements Supplements / Life Science Matters Litigation Eli Lilly, Others Urge 6th Circ. To Toss Darvocet Appeal (subscription required) McNeil Asks Pa. Appeals Court to Boot $10M Motrin Verdict (subscription required) J&J to Pay $4B to Settle Hip Implant Suits (subscription required) J&J Trying to Back Out of 77 Risperdal Deals, Plaintiffs Say (subscription required) Birth Defect Lawyers in Effexor MDL Assigned to Leadership Roles Final Bard Avaulta Vaginal Mesh Bellweather Trial Set for Dec. 3 Stryker Rejuvenate Hip Attorneys Assigned to leadership Positions in MDL Process Outlined for Selecting First Pradaxa Trials in Federal Litigation Whistleblower Payment to Top $165M in Johnson and Johnson Settlement J&J Unit Levied $400M, Admits Off-Label Risperdal Marketing (subscription required) Regulatory FDA Rips Aegerion Exec for Drug Promo Claims on CNBC (subscription required) Juxtapid Maker Gets FDA Warning Letter Over Misleading Statements Brilinta Problems Continue for AstraZeneca, as EU Questions Clinical Trials FDA Labeling Rule Creates Liability Risk for Generic Cos. (subscription required) FDA Rule Would Allow Generics Makers to Update Labels (subscription required) FDA Proposed Generic Drug Rules Could Solve Preemption Problem FDA Notes Increase in Reports Involving Surgical Robot Injuries, Complications FDA Needs Rule Change from DMAA Crackdown, Suit Says (subscription required) Recalls Atossa Genetics Mammary Aspiration Specimen Cytology Test (MASCT) System Kit and ForeCYTE Breast Health Test – Marketing Without Approval or Clearance OxyElite Pro Dietary Supplements by USP Labs: Recall – Products Linked to Liver Illness Baylis Medical TorFlex Transseptal Guiding Sheath Kit Other Interesting Reads NY High Court Mulls Smokers’ Medical Monitoring Claims (subscription required) New Heart Guidelines May Increase Use of Crestor, Lipitor and Other Statins For a look at last week’s important life science headlines, click here. Life Science Matters
This Week’s Life Science Headlines
Litigation
Regulatory
Recalls
Other Interesting Reads
For a look at last week’s important life science headlines, click here.
Life Science Matters
Next ArticleFDA Rule Proposal Could Lead to Liability for Generic Drug Manufacturers